Delivery Order SPE2DB25D3002-SPE2DB25FLREA
- Not listed
- The Defense Logistics Agency awarded a $15,056.25 delivery order to AmerisourceBergen Drug Corp for 200-unit vials of Botox on August 4, 2025, with an ultimate completion date of August 25, 2025. This competitive award utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $3,419.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for 200-unit vials of Botox, with a completion date of June 24, 2025. This is a non-set-aside competitive award executed as a child contract under AmerisourceBergen's broader pharmaceutical supply arrangements with DLA. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite...
- The Defense Logistics Agency awarded a $30,112.50 delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of 200-unit vials of BOTOX under a firm fixed-price contract. The order is due for completion by July 31, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 200-unit vials of BOTOX, valued at $3,419.20, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and is being fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $12,821.85 delivery order to AmerisourceBergen Drug Corp for the supply of Botox 200 unit vials. This firm fixed price contract, with an ultimate completion date of August 14, 2025, represents a direct procurement of the pharmaceutical product without set-aside designation. The award was issued on July 24, 2025, with performance occurring at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order operates as a...
- The Defense Logistics Agency awarded a $5,168.16 delivery order to AmerisourceBergen Drug Corp for 100-unit vials of BOTOX under a firm fixed price contract, with an ultimate completion date of August 13, 2025. This is a non-set-aside, competitively awarded delivery order issued on July 23, 2025, with performance to be completed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a critical pharmaceutical distributor for federal medical procurement,...
- The Defense Logistics Agency awarded a $3,445.44 firm fixed price delivery order to AmerisourceBergen Drug Corp for 100-unit vials of Botox. This competitive award, issued on July 14, 2025, with an ultimate completion date of August 4, 2025, represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The work will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was...
- The Defense Logistics Agency awarded a delivery order valued at $1,722.72 to AmerisourceBergen Drug Corp for 100-unit vials of BOTOX on July 10, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a $3,419.20 delivery order to AmerisourceBergen Drug Corp for 200-unit vials of BOTOX on June 20, 2025, with an ultimate completion date of July 14, 2025. This firm fixed-price contract involves no set-aside designation and represents a competitive award to the prime contractor. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,011.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 200-unit vials of Botox, with an ultimate completion date of August 19, 2025. The contract, which was competitively awarded with no set-aside designation, is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB25D3002Indefinite Delivery Contract
- SPE2DB25D3002-SPE2DB25FLREADelivery Order
The Defense Logistics Agency awarded a $3,613.50 delivery order to AmerisourceBergen Drug Corp for 200-unit vials of Botox under a firm fixed-price contract. The delivery order, issued on August 5, 2025, with an ultimate completion date of August 26, 2025, represents a direct procurement of this pharmaceutical product to support federal medical supply needs. This award was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's established role as a major pharmaceutical distributor and federal healthcare solutions provider positions the company to fulfill critical medical procurement requirements across the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 8/5/25 |